November 3, 2025 | View as Webpage

CEO's Message

Upcoming Events

 

News & Resources

Cancer doesn’t wait. Your screening shouldn’t either.


MedChi invites you to read the recent Baltimore Sun op-ed written by MedChi's 178th president, Dr. Eric Wargotz. Click here to read more.

AMA Advocacy Series Webinar: H.R.1 - The impact on physicians and patients and how the AMA is preparing for state implementation

 

Significant changes to health care are on the horizon now that H.R. 1 has been signed into law: Medicaid eligibility and financing, access to health insurance coverage through Affordable Care Act marketplaces, federal support of medical student loans, and Medicare payment. What do physicians need to know and how can they help their patients navigate these changes? How is the AMA helping state medical associations prepare for implementation?   

 

The AMA is offering this webinar to answer those questions and more on November 5 at 7:30 p.m. CT (8:30 p.m. Eastern). Register now.

 MDH Announces New Combined Respiratory Illness Dashboard

 

The Maryland Department of Health (MDH) recently launched a new dashboard that consolidates COVID-19, influenza, and RSV data, making respiratory virus information easier to access. This new Maryland Combined Respiratory Illness Dashboard provides simplified data for trend analysis while maintaining links to existing dashboards.

 

The new tool features data from various Maryland sources and includes additional information on vaccinations and respiratory illness hospitalizations and deaths. It aims to help Marylanders make informed decisions during the 2025-2026 respiratory season. 

Of course, MDH continues to emphasize vaccination as the best protection against respiratory infections and has enhanced vaccine accessibility through a standing order and updated recommendations. For more information, visit health.maryland.gov/vaccines.

A Message from the Maryland Health Care Commission: "Maryland Health Care Commission Issues Reports on Increasing Primary Care Investment and Enhancing Prior Authorization Processes"


The Maryland Health Care Commission (MHCC) released two reports required by the Maryland General Assembly, about primary care and prior authorization, with recommendations aimed at improving transparency and reducing disparities in Maryland.


“All Marylanders deserve timely access to the care they need, and the foundation of any high-functioning health care system is primary care,” said Dr. Douglas Jacobs, MHCC Executive Director. “Improving access to primary care and increasing the efficiency, transparency, and accountability in the use of prior authorization can reduce wait times, support better health, and an overall experience of our health care system.”


The Primary Care Investment Report highlights stagnating investment in primary care, which contributes to workforce shortages, provider burnout, limited access to care. It underscores the essential role of primary care in reducing disparities and improving health outcomes, and reviews initiatives implemented by nearly 20 states to address challenges in increasing primary care investment. An analysis conducted by MHCC identifies trends among payors and geographic regions in Maryland that present the greatest opportunities to improve access, enhance quality, and reduce disparities through increased investment in primary care.


Additional steps are needed to improve investment in primary care in Maryland. Over the next year, MHCC will collaborate with payors to establish a statewide investment target. The MHCC also plans to analyze the factors that drive variations in spending and identify targeted opportunities to strengthen primary care commitments, with a focus on underserved communities. The MHCC will work with the legislature on additional reforms.  



The Prior Authorization Report includes findings on payors’ and pharmacy benefits managers’ implementation of a State-mandated online process that enables real-time benefit checks at the point of prescribing. Compliance requires use of national standards by July 1, 2026. The online process will streamline prior authorizations by enabling the acceptance and approval of prior authorization requests, identifying patient out-of-pocket costs, and suggesting medication alternatives.


Prior authorization reform at the federal and state levels informed MHCC’s recommendation for greater transparency. The MHCC will explore regulatory options in collaboration with partners across the state to ensure that the coverage criteria used by payors to determine medical necessity is publicly available and grounded in widely accepted treatment guidelines and high-quality clinical literature. The MHCC plans to build provider awareness of electronic prior authorization and real-time benefit check tools to reduce burden on providers and patients, and to improve timely access to care.


More information about MHCC can be found at: https://mhcc.maryland.gov/mhcc/default.aspx

Employment Practices Liability Insurance: What It Covers and Why You Need It


Discover how Employment Practices Liability Insurance (EPLI) shields your business from costly lawsuits—covering discrimination, harassment, and wrongful termination.

Important Update for AARP/UnitedHealthcare Medicare Supplement Members


Policyholders of AARP Medicare Supplement (Medigap) plans insured by UnitedHealthcare can continue to receive care at Johns Hopkins hospitals and from Johns Hopkins Medicine providers. Please visit: Maryland Insurance Administration for more.

Member Opportunities

Bayer is Dedicated to Fighting Prostate Cancer

 

Prostate cancer is one of the most common cancers among men, affecting 1 in 8 during their lifetime. Bayer’s mission—"Health For All, Hunger For None"—serves as our guiding principle as we strive to improve the lives of those impacted by this disease. We believe that every person deserves equal access to education, screening, and treatment, and together, we can help bridge those gaps. Learn more here - Fighting Prostate Cancer | Bayer Global

Pharmacy and Therapeutics Committee Seeking Licensed Physician to Join As Committee Member


To MDAFP and MedChi Colleagues: The Pharmacy and Therapeutics Committee is seeking a licensed physician to join as a committee member. The terms are 3 years and more information about P&T can be found at this link. If you have any members who may be interested in joining please share their information with Michelle Morniningred from the Office of Appointments and Executive Nominations.

Sign Up Now for MedChi’s 2026 Doctor of the Day!


Volunteer to serve in the Maryland State House First Aid Room during the 2026 General Assembly Session. Sign up here. Questions? Contact Hamida Mansaray at hmansaray@medchi.org or call 410-878-9599.

The Maryland Medicaid Office of Pharmacy Services is currently accepting applications for physicians, pharmacists and consumer members. Apply here today!

 

The committee is composed of five physicians, five pharmacists and two consumers living and working in Maryland. They review the Maryland Medicaid preferred drug list and make recommendations to the Secretary of Health for Maryland twice a year. Meetings are held virtually on the first Thursday of November & May.

This Week's Sponsor

Thank you for your support!

Your Advocate. Your Resource. Your Profession.

We Want to Hear From You!

Click here to share your news, suggestions, & ideas!

MedChi, The Maryland State Medical Society

800.492.1056 • www.medchi.org

Email  Facebook  Instagram  LinkedIn  Web  X  YouTube